Kandidatförteckning över SVHC-ämnen för godkännande
Kandidatförteckning över SVHC-ämnen för godkännande
(publicerad i enlighet med artikel 59.10 i Reach-förordningen)
Kandidatförteckning över SVHC-ämnen för godkännande
Anmärkningar:
- Giltig version: Kandidatförteckningen som offentliggörs på den här webbsidan är den enda giltiga förteckningen. Efter att ett ämne tagits med i kandidatförteckningen på denna webbplats kan företag ha omedelbara rättsliga skyldigheter, framför allt inbegripet artiklarna 7, 31 och 33 i Reach-förordningen.
- Numeriska identitetsbeteckningar: Varje post i kandidatförteckningen omfattar både vattenfria och hydratiserade former av ett ämne. CAS-numret som visas i en post är typiskt för den vattenfria formen. Hydratiserade former av ämnet som identifieras av andra CAS-nummer omfattas också av posten.
- Andra numeriska identitetsbeteckningar: Poster med tecknet ”-” i kolumnerna för EG- och CAS-nummer innehåller (där det är praktiskt möjligt) ett icke uttömmande registerutdrag med EG- och/eller CAS-nummer som beskriver ämnen eller ämnesgrupper som bedömts ligga inom ramen för den aktuella posten i kandidatförteckningen. Du får tillgång till denna information genom att klicka på knappen ”Detaljer” vid den valda posten.
Filter the list
The List does not contain any Substances.
Beslut | IUCLID-datauppsättning | ||||||
---|---|---|---|---|---|---|---|
show/hide
(±)-1,7,7-trimethyl-3-[(4-methylphenyl)methylene]bicyclo[2.2.1]heptan-2-one
EG-nr :
253-242-6
| CAS-nr :
36861-47-9
(3E)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-nr :
-
| CAS-nr :
1782069-81-1
(1R,3E,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-nr :
-
| CAS-nr :
95342-41-9
(1S,3E,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-nr :
-
| CAS-nr :
852541-30-1
(1R,3Z,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-nr :
-
| CAS-nr :
852541-21-0
(1R,4S)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-nr :
-
| CAS-nr :
741687-98-9
(1S,3Z,4R)-1,7,7-trimethyl-3-(4-methylbenzylidene)bicyclo[2.2.1]heptan-2-one
EG-nr :
-
| CAS-nr :
852541-25-4
|
-
|
-
|
17-jan-2022
|
Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||
203-794-9
|
110-71-4
|
18-jun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
253-692-3
|
37853-59-1
|
17-jan-2023
|
vPvB (Article 57e) |
Details | |||
202-486-1
|
96-18-4
|
20-jun-2011
|
Carcinogenic (Article 57a) Toxic for reproduction (Article 57c) |
Details | |||
with ≥ 0.3% of dihexyl phthalate (EC No. 201-559-5)
show/hide
1,2-Benzenedicarboxylic acid, mixed decyl and hexyl and octyl diesters
EG-nr :
272-013-1
| CAS-nr :
68648-93-1
|
-
|
-
|
15-jun-2015
|
Toxic for reproduction (Article 57c) |
Details | ||
276-158-1
|
71888-89-6
|
20-jun-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
271-084-6
|
68515-42-4
|
20-jun-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
271-093-5
|
68515-50-4
|
16-jun-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
284-032-2
|
84777-06-0
|
19-dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-977-3
|
112-49-2
|
18-jun-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
203-458-1
|
107-06-2
|
19-dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
211-076-1
|
629-14-1
|
19-dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
219-514-3
|
2451-62-9
|
18-jun-2012
|
Mutagenic (Article 57b) |
Details | |||
-
|
423-400-0
|
59653-74-6
|
18-jun-2012
|
Mutagenic (Article 57b) |
Details | ||
214-317-9
|
1120-71-4
|
17-dec-2015
|
Carcinogenic (Article 57a) |
Details | |||
204-661-8
|
123-91-1
|
08-jul-2021
|
Carcinogenic (Article 57a) Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | |||
covering any of its individual anti- and syn-isomers or any combination thereof
show/hide
(1S,2S,5R,6R,9S,10S,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EG-nr :
-
| CAS-nr :
135821-03-3
(1S,2S,5S,6S,9R,10R,13R,14R)-1,6,7,8,9,14,15,16,17,17,18,18-Dodecachloropentacyclo[12.2.1.1⁶,⁹.0²,¹³.0⁵,¹⁰]octadeca-7,15-diene
EG-nr :
-
| CAS-nr :
135821-74-8
1,6,7,8,9,14,15,16,17,17,18,18-dodecachloropentacyclo[12.2.1.16,9.02,13.05,10]octadeca-7,15-diene
EG-nr :
236-948-9
| CAS-nr :
13560-89-9
|
-
|
-
|
15-jan-2018
|
vPvB (Article 57e) |
Details | ||
3-benzylidene camphor; 3-BC
|
239-139-9
|
15087-24-8
|
15-jan-2019
|
Endocrine disrupting properties (Article 57(f) - environment) |
Details | ||
203-445-0
|
106-94-5
|
19-dec-2012
|
Toxic for reproduction (Article 57c) |
Details | |||
212-828-1
|
872-50-4
|
20-jun-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
214-012-0
|
1072-63-5
|
25-jun-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
201-236-9
|
79-94-7
|
17-jan-2023
|
Carcinogenic (Article 57a) |
Details | |||
202-918-9
|
101-14-4
|
19-dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
AP-5
|
401-720-1
|
6807-17-6
|
15-jan-2019
|
Toxic for reproduction (Article 57c) |
Details | ||
show/hide
|
-
|
-
|
08-jul-2021
|
Carcinogenic (Article 57a) |
Details | ||
covering any of their individual isomers and combinations thereof
show/hide
potassium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propionate
EG-nr :
266-578-3
| CAS-nr :
67118-55-2
|
-
|
-
|
16-jul-2019
|
Equivalent level of concern having probable serious effects to human health (Article 57(f) - human health) Equivalent level of concern having probable serious effects to the environment (Article 57(f) - environment) |
Details | ||
211-989-5
|
732-26-3
|
23-jan-2024
|
Toxic for reproduction (Article 57c) PBT (Article 57d) |
Details | |||
223-383-8
|
3864-99-1
|
17-dec-2015
|
vPvB (Article 57e) |
Details | |||
204-450-0
|
121-14-2
|
13-jan-2010
|
Carcinogenic (Article 57a) |
Details | |||
247-384-8
|
25973-55-1
|
17-dec-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
221-573-5
|
3147-75-9
|
23-jan-2024
|
vPvB (Article 57e) |
Details | |||
253-037-1
|
36437-37-3
|
17-dec-2015
|
vPvB (Article 57e) |
Details | |||
show/hide
|
-
|
-
|
08-jul-2021
|
Toxic for reproduction (Article 57c) |
Details | ||
438-340-0
|
119344-86-4
|
23-jan-2024
|
Toxic for reproduction (Article 57c) |
Details | |||
223-346-6
|
3846-71-7
|
17-dec-2014
|
PBT (Article 57d) vPvB (Article 57e) |
Details | |||
CG 25-369; IRGACURE 369; TK 11-319
|
404-360-3
|
119313-12-1
|
16-jan-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
203-804-1
|
110-80-5
|
15-dec-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
203-839-2
|
111-15-9
|
20-jun-2011
|
Toxic for reproduction (Article 57c) |
Details | |||
239-622-4
|
15571-58-1
|
17-dec-2014
|
Toxic for reproduction (Article 57c) |
Details | |||
201-963-1
|
90-04-0
|
19-dec-2011
|
Carcinogenic (Article 57a) |
Details | |||
203-713-7
|
109-86-4
|
15-dec-2010
|
Toxic for reproduction (Article 57c) |
Details | |||
203-772-9
|
110-49-6
|
16-jul-2019
|
Toxic for reproduction (Article 57c) |
Details | |||
ACETOCURE 97; GENOCURE*PMP; IGM 4817; IRGACURE 907; SPEEDCURE 97
|
400-600-6
|
71868-10-5
|
16-jan-2020
|
Toxic for reproduction (Article 57c) |
Details | ||
211-765-7
|
693-98-1
|
25-jun-2020
|
Toxic for reproduction (Article 57c) |
Details | |||
ZOLDINE MS-PLUS
|
421-150-7
|
143860-04-2
|
19-dec-2012
|
Toxic for reproduction (Article 57c) |
Details | ||
202-974-4
|
101-77-9
|
28-okt-2008
|
Carcinogenic (Article 57a) |
Details | |||
201-025-1
|
77-40-7
|
08-jul-2021
|
Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | |||
with ≥ 0.1% of Michler's ketone (EC No. 202-027-5) or Michler's base (EC No. 202-959-2)
|
209-218-2
|
561-41-1
|
18-jun-2012
|
Carcinogenic (Article 57a) |
Details | ||
202-027-5
|
90-94-8
|
18-jun-2012
|
Carcinogenic (Article 57a) |
Details | |||
Bisphenol A; BPA
|
201-245-8
|
80-05-7
|
12-jan-2017
|
Toxic for reproduction (Article 57c) Endocrine disrupting properties (Article 57(f) - environment) Endocrine disrupting properties (Article 57(f) - human health) |
Details | ||